METiS Pharmaceuticals

METiS Pharmaceuticals is a cutting-edge biotechnology company focused on revolutionizing drug delivery and discovery through the integration of artificial intelligence (AI), machine learning, and quantum simulation. They leverage their unique interdisciplinary technologies to develop more effective therapies across a broad spectrum of diseases, addressing unmet medical needs. METiS has built three core technology platforms: AiLNP, AiRNA, and AiTEM, which predict the physicochemical and biological properties of small molecules and nucleic acid drugs in different microenvironments. These platforms drive the design and optimization of innovative delivery materials, nucleic acid sequences, formulations, and delivery systems.

METiS is founded and led by a team of top scientists from MIT and other leading institutions, including a member of the National Academy of Engineering. The company has a global presence with locations in Hangzhou, Beijing, Shanghai, and Cambridge, Massachusetts. METiS is actively developing a portfolio of over 10 drugs, including small molecules and RNA drugs. They collaborate with domestic and international pharmaceutical companies through joint development pipelines and external licensing, demonstrating their commitment to supporting the entire pharmaceutical ecosystem and driving industry innovation.

METiS Pharmaceuticals is an innovative and open organization dedicated to harnessing cutting-edge technology to develop revolutionary therapies for diseases with significant unmet medical needs. The company's mission is to boldly deliver impactful treatments for patients, fostering a culture of excellence, collaboration, integrity, innovation, and inclusivity to achieve this goal.

METiS Pharmaceuticals fosters a culture that values excellence, collaboration, integrity, and innovation. They encourage a success mentality, teamwork, and open communication, believing in the power of collective effort. They maintain an honest and candid approach while prioritising inclusivity, ensuring every voice is heard and valued, regardless of background or origin. The company's DNA is defined by a relentless pursuit of innovation and a commitment to actively learning and growing, ensuring they remain at the forefront of the drug development industry.

METiS Pharmaceuticals embraces diversity, equity, and inclusion as core values. They actively foster a welcoming and inclusive environment where all employees feel valued and respected, regardless of their background, ethnicity, gender, or any other characteristic. This commitment is reflected in their mission statement, which emphasizes gathering talents with a shared purpose, and their values, which highlight collaboration, integrity, innovation, and inclusiveness. Their efforts ensure that all voices are heard, perspectives are shared, and ideas are valued, creating a thriving and supportive workplace for all.